Skip to content

ENGN - enGene Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

enGene Holdings Inc. Common Stock

ENGN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

ENGNenGene Holdings Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $12.25
52-wk low: $1.40
Prev close: $7.70
Mkt cap: $123.9M
Beta: -0.28
P/B: 0.4x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$9.4M

MW
Marshall Wace
Q1 2026 13F
$2.3M
position
BA
Balyasny
Dmitry Balyasny · Q2 2026 13F

Earnings

Reported Mar 9, 2026

Earnings came in 23.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $124M

Valuation

P/B0.45

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ENGN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $123.93M
Beta: -0.28

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-52.6%

$1.7M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$1.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ENGN

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.44+23.3%

-$0.57 expected

Next report

Reports Sep 10, 2026, in 20 days

EPS expected

-$0.43

-$0.51 to -$0.35

Revenue expected

$0.00

8 analysts

Last 30 days

8up0down

Analysts raising estimates

-52.6%

ROA-28.9%

Growth

Beta-0.28